Back in March, I placed a “Sell” rating on Beyond Meat (NASDAQ:BYND), saying management greatly misread demand for its product. I reiterated my “Sell”...
Investment Thesis In my opinion, Bristol-Myers Squibb (NYSE:BMY) stands at a critical juncture. My forthcoming analysis contends that the company’s valuation and future market...
In my last post, I initiated coverage of Algoma Steel (NASDAQ:ASTL), explaining my reasoning that through Algoma Steel’s current cost model with its Basic...
There are as many prudent dividend strategies as there are dividend investors. However, in this report, we review three specific income-focused portfolio strategies, including:...
This article was written by Seeking Alpha’s transcripts team is responsible for the development of all of our transcript-related projects. We currently publish thousands...